BCB Bancorp, Inc. (BCBP)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
$9.10+2.94%
Close 2026-11-04 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
Research Workspace
Put BCBP beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Regional Banks is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Return to consistent profitability with positive operating income: Comparison needs review.
View ThesisRevenue is contracting — down about 9% over the past year.
View GrowthManagement screens weak on capital allocation, earnings delivery, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskBCBP's credit portfolio cleanup has to keep compounding to justify the price. Revenue fell 6.3% in the prior quarter. The latest quarter beat estimates by 5.9%. It trades at 0.5x book value versus a 1.2x peer median. The price reflects less growth than we forecast. The primary profitability pillar is under pressure. The thesis comparison is not yet verified. Peer multiples imply a price about 60% above where it trades. The thesis is on watch. This read is provisional.
Trailing returns as of 2026-11-04. BCBP is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 3 analysts currently covering BCBP (as of Nov 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare BCBP with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BCBP Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Regional Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put BCBP next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Financial restructuring and credit portfolio review
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Planned cannabis-loan sale follows a market-value review, advancing portfolio restructuring and credit-risk reduction.
Advances: Financial restructuring and credit portfolio review
Reported Q3 cleanup signals progress on financial restructuring and credit portfolio review.
Threatens: Preserve capital by suspending quarterly cash dividends
Dilutive offering impacts capital preservation objective.
Advances: Financial restructuring and credit portfolio review
Raising capital supports financial restructuring efforts.
Advances: Preserve capital by suspending quarterly cash dividends
Stock offering supports capital preservation objective.
Threatens: Preserve capital by suspending quarterly cash dividends
Stock offering may dilute capital and affect dividend suspension.
Threatens: Financial restructuring and credit portfolio review
Loan losses impact financial restructuring efforts.
Leadership transition aligns with strategic priorities.